Interleukin-12 Antagonist [EPC]

60609 reported adverse events

Drugs of this class: USTEKINUMAB

These side effects are most commonly reported by patients taking drugs of the Interleukin-12 Antagonist [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 7931
1 OFF LABEL USE 5947
2 PSORIASIS 4809
3 PRODUCT USE ISSUE 3185
4 CROHN^S DISEASE 2798
5 FATIGUE 2449
6 PNEUMONIA 2215
7 HEADACHE 2163
8 PAIN 2135
9 ARTHRALGIA 2128
See all common reactions for Interleukin-12 Antagonist [EPC]

Drugs of the Interleukin-12 Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 RED BLOOD CELL SEDIMENTATION RATE 82 0.4940
1 SWOLLEN JOINT COUNT INCREASED 144 0.4472
2 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 711 0.3994
3 RHEUMATOID FACTOR POSITIVE 652 0.3038
4 RHEUMATIC FEVER 156 0.2836
5 CONTRAINDICATION TO VACCINATION 38 0.2275
6 ENTHESOPATHY 198 0.2145
7 PITYRIASIS RUBRA PILARIS 23 0.1840
8 GRANULOMA SKIN 92 0.1685
9 PEMPHIGUS 738 0.1579
See all enriched reactions for Interleukin-12 Antagonist [EPC]